Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Mini Sentinel Alleviates FDA Concern Over Pradaxa Bleeding Issue

Nov 02 2012

• By Derrick Gingery

Related Content

FDASIA Study Mandates Focus On Performance, But Could Slow Reviews

Aug 20 2012

Pradaxa Bleeding Deaths Spur FDA Concerns, European Label Changes

Dec 07 2011

FDA Plays It Safe With Boehringer Ingelheim's Pradaxa By Approving A Single Dosing Option

Oct 20 2010

Pradaxa’s U.S. Label Updated To Cite Clinical Superiority To Warfarin In Stroke Prevention

Jun 11 2012

Mini Sentinel Data Covers 126 Million Patients; FDA Weighing Potential Uses For Drug Industry

Jan 23 2012

Related Companies

Boehringer Ingelheim GmbH

Additional Topics

United States Safety Risk Management BioPharmaceutical

More from United States

More from North America

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window